questionsmedicales.fr
Disciplines et activités comportementales
Psychothérapie
Thérapie socio-environnementale
Thérapie socio-environnementale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Complement Membrane Attack Complex
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie socio-environnementale : Questions médicales les plus fréquentes",
"headline": "Thérapie socio-environnementale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie socio-environnementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-18",
"dateModified": "2025-05-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie socio-environnementale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Psychothérapie",
"url": "https://questionsmedicales.fr/mesh/D011613",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Psychothérapie par le milieu",
"alternateName": "Milieu Therapy",
"url": "https://questionsmedicales.fr/mesh/D008884",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie par le milieu",
"code": {
"@type": "MedicalCode",
"code": "D008884",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.392"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Communauté thérapeutique",
"alternateName": "Therapeutic Community",
"url": "https://questionsmedicales.fr/mesh/D013808",
"about": {
"@type": "MedicalCondition",
"name": "Communauté thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.392.701"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Psychothérapie de groupe",
"alternateName": "Psychotherapy, Group",
"url": "https://questionsmedicales.fr/mesh/D011615",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie de groupe",
"code": {
"@type": "MedicalCode",
"code": "D011615",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie de couple",
"alternateName": "Couples Therapy",
"url": "https://questionsmedicales.fr/mesh/D019546",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie de couple",
"code": {
"@type": "MedicalCode",
"code": "D019546",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.136"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie conjugale",
"alternateName": "Marital Therapy",
"url": "https://questionsmedicales.fr/mesh/D008388",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie conjugale",
"code": {
"@type": "MedicalCode",
"code": "D008388",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.136.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie conjugale",
"alternateName": "Marital Therapy",
"url": "https://questionsmedicales.fr/mesh/D008388",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie conjugale",
"code": {
"@type": "MedicalCode",
"code": "D008388",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.136.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie familiale",
"alternateName": "Family Therapy",
"url": "https://questionsmedicales.fr/mesh/D005196",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie familiale",
"code": {
"@type": "MedicalCode",
"code": "D005196",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.273"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Psychodrame",
"alternateName": "Psychodrama",
"url": "https://questionsmedicales.fr/mesh/D011577",
"about": {
"@type": "MedicalCondition",
"name": "Psychodrame",
"code": {
"@type": "MedicalCode",
"code": "D011577",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.679"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Jeu de rôle",
"alternateName": "Role Playing",
"url": "https://questionsmedicales.fr/mesh/D012381",
"about": {
"@type": "MedicalCondition",
"name": "Jeu de rôle",
"code": {
"@type": "MedicalCode",
"code": "D012381",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.679.653"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Jeu de rôle",
"alternateName": "Role Playing",
"url": "https://questionsmedicales.fr/mesh/D012381",
"about": {
"@type": "MedicalCondition",
"name": "Jeu de rôle",
"code": {
"@type": "MedicalCode",
"code": "D012381",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.679.653"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Groupes d'apprentissage en commun",
"alternateName": "Sensitivity Training Groups",
"url": "https://questionsmedicales.fr/mesh/D012681",
"about": {
"@type": "MedicalCondition",
"name": "Groupes d'apprentissage en commun",
"code": {
"@type": "MedicalCode",
"code": "D012681",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.813"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Traitement résidentiel",
"alternateName": "Residential Treatment",
"url": "https://questionsmedicales.fr/mesh/D012114",
"about": {
"@type": "MedicalCondition",
"name": "Traitement résidentiel",
"code": {
"@type": "MedicalCode",
"code": "D012114",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.696"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thérapie socio-environnementale",
"alternateName": "Socioenvironmental Therapy",
"code": {
"@type": "MedicalCode",
"code": "D012960",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Terri A deRoon-Cassini",
"url": "https://questionsmedicales.fr/author/Terri%20A%20deRoon-Cassini",
"affiliation": {
"@type": "Organization",
"name": "Medical College of Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Guangrong Zheng",
"url": "https://questionsmedicales.fr/author/Guangrong%20Zheng",
"affiliation": {
"@type": "Organization",
"name": "College of Pharmacy, University of Florida, Gainesville, FL, USA."
}
},
{
"@type": "Person",
"name": "Vargas Del Río David",
"url": "https://questionsmedicales.fr/author/Vargas%20Del%20R%C3%ADo%20David",
"affiliation": {
"@type": "Organization",
"name": "Department of Habitat and Human Development. Periférico Sur Manuel Gómez Morín 8585, Instituto Tecnológico y de Estudios Superiores de Occidente, Santa María Tequepexpan, San Pedro Tlaquepaque, Jal 45604, Mexico."
}
},
{
"@type": "Person",
"name": "Brenner Ludger",
"url": "https://questionsmedicales.fr/author/Brenner%20Ludger",
"affiliation": {
"@type": "Organization",
"name": "Unidad Iztapalapa, Department of Sociology, Universidad Autónoma Metropolitana, Avenida San Rafael Atlixco 186, Mexico City 09340, Mexico."
}
},
{
"@type": "Person",
"name": "Natalia Hanazaki",
"url": "https://questionsmedicales.fr/author/Natalia%20Hanazaki",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Ecologia E Zoologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Campus Universitário S/N, Florianópolis, SC, 88040-900, Brazil. natalia.hanazaki@ufsc.br."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35820290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.preghy.2022.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Increased plasma level of terminal complement complex in AMD patients: potential functional consequences for RPE cells.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37359546",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1200725"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lipopolysaccharides and outer membrane proteins as main structures involved in complement evasion strategies of non-typhoidal Salmonella strains.",
"datePublished": "2022-08-20",
"url": "https://questionsmedicales.fr/article/35998438",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.molimm.2022.08.009"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pitfalls in complement analysis: A systematic literature review of assessing complement activation.",
"datePublished": "2022-10-18",
"url": "https://questionsmedicales.fr/article/36330514",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1007102"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients.",
"datePublished": "2023-05-08",
"url": "https://questionsmedicales.fr/article/37244049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.prp.2023.154519"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie socio-environnementale",
"item": "https://questionsmedicales.fr/mesh/D012960"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie socio-environnementale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie socio-environnementale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie socio-environnementale",
"description": "Comment évaluer l'impact de l'environnement sur la santé ?\nQuels outils sont utilisés pour le diagnostic ?\nQuels professionnels participent au diagnostic ?\nComment identifier les besoins socio-environnementaux ?\nQuelles échelles mesurent le bien-être social ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie socio-environnementale",
"description": "Quels symptômes indiquent un besoin de thérapie socio-environnementale ?\nComment l'environnement influence-t-il les symptômes ?\nQuels signes de détresse sociale sont observables ?\nLes symptômes varient-ils selon l'âge ?\nQuels symptômes physiques peuvent être liés à des facteurs sociaux ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie socio-environnementale",
"description": "Comment prévenir les problèmes socio-environnementaux ?\nQuels programmes de prévention existent ?\nQuel rôle joue la communauté dans la prévention ?\nComment évaluer l'efficacité des mesures préventives ?\nQuels facteurs de risque peuvent être ciblés ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie socio-environnementale",
"description": "Quels types de traitements sont offerts ?\nComment la thérapie de groupe aide-t-elle ?\nQuel rôle joue le counseling individuel ?\nComment les interventions communautaires sont-elles mises en œuvre ?\nQuels résultats attendus des traitements socio-environnementaux ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie socio-environnementale",
"description": "Quelles complications peuvent survenir sans traitement ?\nComment les complications affectent-elles la qualité de vie ?\nQuels impacts sur la santé physique peuvent être observés ?\nLes complications sont-elles réversibles ?\nComment prévenir les complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie socio-environnementale",
"description": "Quels facteurs de risque socio-environnementaux existent ?\nComment le stress environnemental influence-t-il la santé ?\nQuel rôle joue le soutien social dans la santé ?\nLes antécédents familiaux influencent-ils les risques ?\nComment l'accès aux ressources affecte-t-il la santé ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact de l'environnement sur la santé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des questionnaires et des entretiens sur les conditions de vie."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles de mesure et des outils d'évaluation psychosociale sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels professionnels participent au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Psychologues, travailleurs sociaux et médecins collaborent pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Comment identifier les besoins socio-environnementaux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les besoins sont identifiés par des entretiens et des observations sur le terrain."
}
},
{
"@type": "Question",
"name": "Quelles échelles mesurent le bien-être social ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles comme le SWLS (Satisfaction With Life Scale) sont utilisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie socio-environnementale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes de stress, d'anxiété, d'isolement social ou de dépression peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement stressant peut aggraver les symptômes psychologiques et physiques."
}
},
{
"@type": "Question",
"name": "Quels signes de détresse sociale sont observables ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Isolement, conflits familiaux et difficultés relationnelles sont des signes de détresse."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et des expériences de vie."
}
},
{
"@type": "Question",
"name": "Quels symptômes physiques peuvent être liés à des facteurs sociaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, douleurs chroniques et troubles du sommeil peuvent être liés à des facteurs sociaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les problèmes socio-environnementaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, le soutien communautaire et l'amélioration des conditions de vie."
}
},
{
"@type": "Question",
"name": "Quels programmes de prévention existent ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de sensibilisation et des ateliers de compétences sociales sont disponibles."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la communauté dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La communauté peut offrir un soutien, des ressources et des activités pour renforcer les liens."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des mesures préventives ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études de suivi et des retours d'expérience des participants."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque peuvent être ciblés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs comme l'isolement social et le stress environnemental peuvent être ciblés."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont offerts ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie de groupe, le counseling et des interventions communautaires."
}
},
{
"@type": "Question",
"name": "Comment la thérapie de groupe aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle favorise le soutien social et l'échange d'expériences entre participants."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le counseling individuel ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le counseling aide à identifier des stratégies personnelles pour faire face aux défis."
}
},
{
"@type": "Question",
"name": "Comment les interventions communautaires sont-elles mises en œuvre ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont mises en œuvre par des programmes de sensibilisation et des activités de groupe."
}
},
{
"@type": "Question",
"name": "Quels résultats attendus des traitements socio-environnementaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Amélioration du bien-être, réduction des symptômes et renforcement des liens sociaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, des complications comme la dépression chronique et l'isolement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie, affecter les relations et la santé physique."
}
},
{
"@type": "Question",
"name": "Quels impacts sur la santé physique peuvent être observés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cardiovasculaires et des problèmes immunitaires peuvent être exacerbés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et un soutien."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un suivi régulier et des interventions précoces adaptées."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque socio-environnementaux existent ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Isolement social, pauvreté et conditions de vie précaires sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Comment le stress environnemental influence-t-il la santé ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress environnemental peut aggraver les troubles mentaux et physiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le soutien social dans la santé ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bon soutien social réduit le risque de troubles mentaux et améliore le bien-être."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles mentaux augmentent le risque individuel."
}
},
{
"@type": "Question",
"name": "Comment l'accès aux ressources affecte-t-il la santé ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un accès limité aux ressources augmente le risque de problèmes de santé physique et mentale."
}
}
]
}
]
}
We sought to determine if soluble levels of C5b-9, the terminal complement complex, correlate with end-organ injury in preeclampsia....
Project COPA (Complement and Preeclampsia in the Americas), a multi-center observational study in Colombia from 2015 to 2016, enrolled hypertensive pregnant women into four groups: chronic hypertensio...
C5b-9 concentrations in plasma and urine, using enzyme linked immunosorbent assays....
In total, 298 hypertensive participants were enrolled. Plasma and urine C5b-9 levels were measured in all participants and stratified by quartile (Q1-4), from lowest to highest C5b-9 concentration. Pa...
We identified a pattern of increased urine and low plasma C5b-9 levels in patients with preeclampsia and end-organ injury. Soluble C5b-9 levels may be used to identify complement-mediated end-organ in...
Polymorphisms in complement genes are risk-associated for age-related macular degeneration (AMD). Functional analysis revealed a common deficiency to control the alternative complement pathway by risk...
Collection of plasma from patients with wet AMD (n = 87: 62% female and 38% male; median age 77 years) and controls (n = 86: 39% female and 61% male; median age 58 years), grouped for risk factor smok...
Genotyping, measurement of TCC concentrations, ARPE-19 cell culture, Ca...
TCC concentration in plasma, intracellular free Ca...
TCC levels in the plasma of AMD patients were five times higher than in non-AMD controls but did not differ in plasma from carriers of the two risk alleles. Complement-evoked Ca...
TCC levels were higher in AMD patients but did not depend on genetic risk factors. The Ca...
Non-typhoidal Salmonella (NTS) infections pose a serious public health problem. In addition to the typical course of salmonellosis, an infection with Salmonella bacteria can often lead to parenteral i...
The complement system is an essential component of our innate defense and plays a vital role in the pathogenesis of many diseases. Assessment of complement activation is critical in monitoring both di...
We performed a systematic analysis of the current methods used to assess complement components and reviewed whether the identified studies performed their complement measurements according to the reco...
A literature search using the Pubmed/MEDLINE database was performed focusing on studies measuring the key complement components C3, C5 and/or their split products and/or the soluble variant of the ter...
A total of 92 out of 376 studies were selected for full-text analysis. Forty-five studies (49%) were identified as using the correct sample type and techniques for their complement analyses, while 25 ...
A substantial part of the reviewed studies did not use the appropriate sample type for assessing complement activation or did not mention which sample type was used. This deviation from the standardiz...
We explored the pathological changes and the activation of local complement system in COVID-19 pneumonia. Lung paraffin sections of COVID-19 infected patients were analyzed by HE (hematoxylin-eosin) s...
Myasthenia gravis is a neuromuscular disease associated with antibodies against components of the neuromuscular junction, most often against the acetylcholine receptor (AChR). Although several mechani...
Bacterial and mitochondrial DNA, sharing an evolutionary origin, act as danger-associated molecular patterns in infectious and sterile inflammation. They both contain immunomodulatory CpG motifs. Inte...
Atypical hemolytic uremic syndrome (aHUS) is a rare kidney disease caused by dysregulation of the complement alternative pathway. The complement dysregulation specifically leads to damage to the glome...
Endothelial cells were incubated with human test sera and stained with an anti-C5b-9 antibody to visualize and quantify complement depositions on the cells with immunofluorescence microscopy....
First, we showed that zymosan-activated sera resulted in increased endothelial C5b-9 depositions compared to normal human serum (NHS). The levels of C5b-9 depositions were similar between conditionall...
In conclusion, we demonstrate a robust and reliable model to adequately measure C5b-9-based complement deposition on human control and patient ciGMVECs. This model can be used to study the pathophysio...
Complement is involved in the pathogenesis of neuroimmune disease, but the detailed pathological roles of the complement pathway remain incompletely understood. Recently, eculizumab, a humanized anti-...
Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction (NMJ) of skeletal muscle. Complement activation is one of the mechanisms by which anti-acetylcholine receptor (anti...
In this single-center, observational study of 45 patients with anti-AChR-antibody-positive generalized MG, serum concentrations of major components of the complement pathways, including C1q, C5, C5a, ...
The patients with MG exhibited lower serum levels of C5 (p = .0001) and higher serum levels of sC5b-9 (p = .004) compared with the control group. At about 6 months (range, 172-209 days) after the star...
Herein, we provide evidence for the activation of the classical complement pathway and its association with disease activity in anti-AChR-antibody-positive generalized MG....